drugset / Trial / NCT05222724

Efficacy of the Combination of Ibuprofen and Paracetamol in Acute Non-specific Low Back Pain

NCT05222724 ↗

Phase 4 Completed 176 enrolled Angelini Pharma TFS Trial Form Support · collab
RandomizedParallel-groupOpen-labelTreatment

Summary

The aim of the present study is to assess the efficacy and safety of paracetamol/ibuprofen Fixed Dose Combination (FDC) compared to ibuprofen in patients with uncomplicated non-specific acute low back pain after a 3-day treatment period.

Timeline

Start
2021-12-01
Primary completion
2022-10-05
Completion
2022-10-05

Drugs

EvaluationDrugModalityDoseRoute
Subject Acetaminophen Small molecule 1000 mg —
Comparator Ibuprofen Small molecule 300 mg —
Comparator Ibuprofen Small molecule 600 mg —

Indications

No indication recorded.